APA (7th ed.) Citation

Z, Q., X, Q., R, H., & J, Y. (2026). Development, characterization, and evaluation of the therapeutic efficacy of PEGylated-nanoliposomal artesunate in mice bearing non-small cell lung carcinoma. Naunyn-Schmiedeberg's archives of pharmacology, 399(9), 14439. https://doi.org/10.1007/s00210-026-05279-9

Chicago Style (17th ed.) Citation

Z, Qin, Qiao X, Huang R, and Yu J. "Development, Characterization, and Evaluation of the Therapeutic Efficacy of PEGylated-nanoliposomal Artesunate in Mice Bearing Non-small Cell Lung Carcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 9 (2026): 14439. https://doi.org/10.1007/s00210-026-05279-9.

MLA (9th ed.) Citation

Z, Qin, et al. "Development, Characterization, and Evaluation of the Therapeutic Efficacy of PEGylated-nanoliposomal Artesunate in Mice Bearing Non-small Cell Lung Carcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 9, 2026, p. 14439, https://doi.org/10.1007/s00210-026-05279-9.